Fritextsökning
Innehållstyper
-
List: The coolest names in biotech
Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...
-
Tirzepatide approved for obesity by the FDA – to be branded as Zepbound
Diabetes drug tirzepatide has now also been approved in the US for treating obesity.
-
“Photon counting in computed tomography is the holy grail”
Erik Fredenberg, a researcher in physics at KTH and GE, is working to implement photon-counting CT in clinics. To shorten lead times and reduce the radiation do...
-
Bio Europe intar Stockholm i höst – ”Det svenska ekosystemet tar nu tillfället i akt”
Den internationella life science-konferensen Bio Europe kommer i november för första gången till Sverige. Konferensen, vars program tar inspiration av ABBA-låta...
-
Settlement of cancer allegations against blockbuster drug
French pharmaceutical company Sanofi has reached a principal agreement in the US on around 4,000 of the cases in which its now withdrawn blockbuster heartburn d...
-
Brexit creeping closer – or?
In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.
-
Norway finds its path in life science
The life science sector in Norway is on the rise.
-
Isländskt bolag tar över delar av Xbrane – planerar ”stark närvaro” i svensk life science
Xbrane säljer sin FoU-verksamhet med 40 anställda, och ett av sina biosimilarprojekt, till isländska Alvotech. Prislappen landar på 275 miljoner kronor – och Xb...
-
AstraZeneca moves to brewery quarters in central Copenhagen
AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.
-
”We need compatibility“
Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...
-
From spin-off to phase II
”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.
-
Clean solutions - Handling viscose substances with precision
Laboratories in the chemical, petrochemical, pharmaceutical and food technology industries are increasingly relying on automation for sample preparation. The Mo...
-
Venom from the deathstalker carries radiopharmaceuticals to the brain
In order to target cancerous brain tumours with radionuclides, the problematic blood-brain barrier must first be crossed. Life Science Sweden has visited a KI r...
-
Sweden and Denmark – this is how they choose their strategies
Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.
-
Ny mjukvara ger dig full koll på dina massflödesprodukter
Håll koll på flödet med Windows-baserad mjukvara från Brooks.
-
Julefrid ger läsetid – 10 artikeltips från redaktionen
När julstöket är avklarat, magen fått sitt och släkten avlägsnat sig lägger sig den stora friden – och kanske vaknar läslusten?
-
He saved lives with his theories – was ostracised and ended up in a mental hospital
Hungarian doctor Ignaz Semmelweis (1818-1865) undoubtedly possessed plenty of persistence, diligence and sound reasoning skills – but he was hardly blessed with...
-
New features in ZEISS CALYPSO 2024
ZEISS CALYPSO is your universal software for dimensional metrology applications.
-
Källor: CDC planerar studie av vacciner och autism
Samtidigt som USA har sitt största mässlingsutbrott på decennier planerar landets smittskyddsmyndighet en studie om koppling mellan autism och vaccin, enligt kä...
-
“We are Europe’s hotspot in life science”
The Medicon Valley Alliance has worked for competence development in life science in Denmark and Sweden for a quarter of a century. Anette Steenberg, CEO, sees ...
-
Drug development creates new challenges for regulators
-
Delivering drugs with small devices
There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...
-
Leqembi godkänt i EU – ”Vi har väntat väldigt länge”
Bioartics läkemedel Leqembi (lecanemab) mot Alzheimers sjukdom har efter flera turer fått godkänt i EU. Det innebär att det för första gången finns ett godkänt ...
-
Första pillret mot förlossningsdepression godkänt i USA
Den första orala behandlingen specifikt inriktad på förlossningsdepression har godkänts av FDA.